Evidence map›Paper›PMID 35807059›Full record

ArticleJournal of clinical medicine2022

Comorbidity and Prognosis in Octogenarians with Infective Endocarditis.

Jose-Angel Perez-Rivera, Carlos Armiñanzas, Patricia Muñoz, Martha Kestler, Blanca Pinilla, Maria-Carmen Fariñas, Ignacio Alvarez-Rodriguez, Guillermo Cuervo, Angeles Rodriguez-Esteban, Aristides de Alarcón and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Dalbavancin as consolidation therapy for infective endocarditis in patients with comorbidity. A real world experience.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 1 country.

Jose-Angel Perez-RiveraUnidad Especializada de Insuficiencia Cardiaca, Servicio de Cardiología, Hospital Universitario de Burgos, Universidad Isabel I, 09003 Burgos, Spain.ORCID 0000-0003-1451-1445
Carlos ArmiñanzasServicio de Enfermedades Infecciosas Hospital Universitario Marqués de Valdecilla IDIVAL, 39008 Santander, Spain.
Patricia MuñozServicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, CIBER Enfermedades Respiratorias-CIBERES (CB06/06/0058), Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Martha KestlerServicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-3307-1545
Blanca PinillaServicio de Medicina Interna, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Maria-Carmen FariñasServicio de Enfermedades Infecciosas Hospital Universitario Marqués de Valdecilla IDIVAL, CIBER de Enfermedades Infecciosas-CIBERINFEC (CB21/13/00068), Instituto de Salud Carlos III, Universidad de Cantabria, 39008 Santander, Spain.
Ignacio Alvarez-RodriguezServicio de Enfermedades Infecciosas, Hospital Donostia, OSI Donostialdea, 20014 San Sebastián, Spain.ORCID 0000-0003-4902-3409
Guillermo CuervoServicio de Enfermedades Infecciosas, Hospital Clinic-IDIBAPS, Universidad de Barcelona, 08036 Barcelona, Spain.
Angeles Rodriguez-EstebanServicio de UCI Cirugía Cardiaca, Hospital Central de Asturias, 33011 Oviedo, Spain.ORCID 0000-0001-7393-2501
Aristides de AlarcónClinical Unit of Infectious Diseases, Microbiology, and Preventive Medicine Infectious Diseases Research Group Institute of Biomedicine of Seville (IBiS), University of Seville/CSIC/University Hospital Virgen del Rocío, 41013 Seville, Spain.
Andrea Gutiérrez-VillanuevaUnidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Universitario Puerta de Hierro, Majadahonda, 28222 Madrid, Spain.
Ana Pello-LazaroServicio de Cardiología, Unidad de Hospitalización, IIS-Fundación Jiménez Díaz, 28040 Madrid, Spain.
Manuel Martínez SellésServicio de Cardiología, Hospital General Universitario Gregorio Marañón, CIBERCV, Universidad Complutense, 28040 Madrid, Spain.ORCID 0000-0003-0289-6229
On Behalf Of The Spanish Collaboration On Endocarditis-Grupo de Apoyo Al Manejo de la Endocarditis Infecciosa En ESpaña Games
Hospital General Universitario Gregorio Marañón · ESBiogipuzkoa Health Research Institute · ESHospital Clínic de Barcelona · ESHospital Universitario Central de Asturias · ESHospital Universitario de Burgos · ESHospital Universitario Fundación Jiménez Díaz · ESHospital Universitario Puerta de Hierro Majadahonda · ESInstituto de Biomedicina de Sevilla · ESInstituto de Investigación Marqués de Valdecilla · ESUniversidad Complutense de Madrid · ESUniversidad de Cantabria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background. Infective endocarditis (IE) in older patients is associated with a high morbidity, mortality, and functional impairment. The purpose of this study was to describe the current profile of IE in octogenarians and to analyze the prognostic impact of baseline comorbidities in this population. Methods. Patients ≥ 80 years and definite IE from the Spanish IE Prospective Database were included. The effect of Charlson Comorbidity Index (CCI) on in-hospital and 12-month mortality was analyzed. Results. From 726 patients, 357 (49%) had CCI ≥ 3 and 369 (51%) CCI < 3. A total of 265 patients (36.6%) died during hospital admission and 338 (45.5%) during 1-year follow-up. CCI ≥ 3 was an independent predictor of in-hospital and 1-year mortality (odds ratio 1.46, 95% confidence interval 1.07−1.99, p = 0.017; hazard ratio 1.34, 95% confidence interval 1.08−1.66, p = 0.007, respectively). Surgical management was less common in patients with high comorbidity (CCI ≥ 3 68 [19.0%] vs. CCI < 3 112 ((30.4%) patients, p < 0.01). From 443 patients with surgical indication, surgery was only performed in 176 (39.7%). Patients with surgical indication treated conservatively had higher mortality than those treated with surgery (in-hospital mortality: 147 (55.1%) vs. 55 (31.3%), p < 0.001), (1-year mortality: 172 (64.4%) vs. 68 [38.6%], p < 0.001). Conclusion. About half of octogenarians with IE had high comorbidity with CCI ≥ 3. CCI ≥ 3 was a strong independent predictor of in-hospital and 1-year mortality. Our data suggest that the underperformance of cardiac surgery in this group of patients might have a role in their poor prognosis.

Indexed as

ageCharlson indexcomorbidityendocarditissurgery

Identifiers

PMID35807059
PMCPMC9267499
OpenAlexW4283754321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.